Agilent Technologies Income from Continuous Operations 2010-2025 | A

Agilent Technologies annual/quarterly income from continuous operations history and growth rate from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • Agilent Technologies income from continuous operations for the quarter ending April 30, 2025 was $215M, a 30.19% decline year-over-year.
  • Agilent Technologies income from continuous operations for the twelve months ending April 30, 2025 was $1.166B, a 6.12% decline year-over-year.
  • Agilent Technologies annual income from continuous operations for 2024 was $1.289B, a 3.95% increase from 2023.
  • Agilent Technologies annual income from continuous operations for 2023 was $1.24B, a 1.12% decline from 2022.
  • Agilent Technologies annual income from continuous operations for 2022 was $1.254B, a 3.64% increase from 2021.
Agilent Technologies Annual Income from Continuous Operations
(Millions of US $)
2024 $1,289
2023 $1,240
2022 $1,254
2021 $1,210
2020 $719
2019 $1,071
2018 $316
2017 $684
2016 $462
2015 $438
2014 $232
2013 $225
2012 $1,153
2011 $1,012
2010 $684
2009 $-31
Agilent Technologies Quarterly Income from Continuous Operations
(Millions of US $)
2025-04-30 $215
2025-01-31 $318
2024-10-31 $351
2024-07-31 $282
2024-04-30 $308
2024-01-31 $348
2023-10-31 $475
2023-07-31 $111
2023-04-30 $302
2023-01-31 $352
2022-10-31 $368
2022-07-31 $329
2022-04-30 $274
2022-01-31 $283
2021-10-31 $442
2021-07-31 $264
2021-04-30 $216
2021-01-31 $288
2020-10-31 $222
2020-07-31 $199
2020-04-30 $101
2020-01-31 $197
2019-10-31 $194
2019-07-31 $191
2019-04-30 $182
2019-01-31 $504
2018-10-31 $195
2018-07-31 $236
2018-04-30 $205
2018-01-31 $-320
2017-10-31 $177
2017-07-31 $175
2017-04-30 $164
2017-01-31 $168
2016-10-31 $126
2016-07-31 $124
2016-04-30 $91
2016-01-31 $121
2015-10-31 $140
2015-07-31 $113
2015-04-30 $92
2015-01-31 $93
2014-10-31 $16
2014-07-31 $63
2014-04-30 $40
2014-01-31 $121
2013-10-31 $211
2013-07-31 $168
2013-04-30 $166
2013-01-31 $179
2012-10-31 $425
2012-07-31 $243
2012-04-30 $255
2012-01-31 $230
2011-10-31 $289
2011-07-31 $330
2011-04-30 $200
2011-01-31 $193
2010-10-31 $292
2010-07-31 $205
2010-04-30 $108
2010-01-31 $79
2009-10-31 $25
2009-07-31 $-19
2009-04-30 $-101
2009-01-31 $64
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $32.241B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $221.543B 25.98
Boston Scientific (BSX) United States $155.948B 37.25
Stryker (SYK) United States $144.198B 29.40
EssilorLuxottica (ESLOY) France $136.878B 0.00
Medtronic (MDT) Ireland $114.582B 16.24
Lonza Group Ag (LZAGY) Switzerland $48.915B 0.00
Haleon (HLN) United Kingdom $43.396B 24.77
ResMed (RMD) United States $40.938B 29.24
GE HealthCare Technologies (GEHC) United States $31.891B 14.99
Koninklijke Philips (PHG) Netherlands $25.479B 16.85
Terumo (TRUMY) Japan $25.170B 32.69
Insulet (PODD) United States $20.051B 78.70
Zimmer Biomet Holdings (ZBH) United States $17.929B 11.52
Smith & Nephew SNATS (SNN) United Kingdom $13.503B 0.00
Baxter (BAX) United States $11.269B 8.71
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $7.745B 28.29
Lantheus Holdings (LNTH) United States $4.882B 12.32
Perrigo (PRGO) Ireland $3.662B 9.28
Prestige Consumer Healthcare (PBH) United States $3.643B 16.27
Haemonetics (HAE) United States $3.592B 16.36
Envista Holdings (NVST) United States $3.462B 24.22
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.136B 23.12
LeMaitre Vascular (LMAT) United States $1.831B 40.93
AtriCure (ATRC) United States $1.710B 0.00
QuidelOrtho (QDEL) United States $1.543B 10.61
Green Thumb Industries (GTBIF) United States $1.429B 32.14
Acuren (TIC) United States $1.340B 0.00
AdaptHealth (AHCO) United States $1.181B 11.99
Phibro Animal Health (PAHC) United States $1.058B 13.53
Neogen (NEOG) United States $1.012B 16.07
BioLife Solutions (BLFS) United States $0.995B 0.00
Curaleaf Holdings (CURLF) Canada $0.954B 0.00
InMode (INMD) Israel $0.868B 8.04
Kestra Medical Technologies (KMTS) United States $0.790B 0.00
Valneva SE (VALN) France $0.614B 0.00
Evolus (EOLS) United States $0.590B 0.00
Tilray Brands (TLRY) Canada $0.572B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.565B 0.00
ZimVie (ZIMV) United States $0.529B 20.39
Surmodics (SRDX) United States $0.515B 0.00
CeriBell (CBLL) United States $0.511B 0.00
Owens & Minor (OMI) United States $0.508B 4.21
SNDL (SNDL) Canada $0.434B 0.00
Capricor Therapeutics (CAPR) United States $0.361B 0.00
Sanuwave Health (SNWV) United States $0.311B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Cresco Labs (CRLBF) United States $0.304B 0.00
VAREX IMAGING (VREX) United States $0.296B 10.88
Quanterix (QTRX) United States $0.293B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.67
Cerus (CERS) United States $0.243B 0.00
Verano Holdings (VRNOF) United States $0.239B 0.00
Viemed Healthcare (VMD) United States $0.234B 19.77
OraSure Technologies (OSUR) United States $0.225B 0.00
Omeros (OMER) United States $0.223B 0.00
Brainsway (BWAY) Israel $0.217B 57.35
Canopy Growth (CGC) Canada $0.215B 0.00
Sanara MedTech (SMTI) United States $0.215B 0.00
Biote (BTMD) United States $0.213B 5.98
Vireo Growth (VREOF) United States $0.196B 0.00
Exagen (XGN) United States $0.190B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.69
Organigram Global (OGI) Canada $0.178B 0.00
High Tide (HITI) Canada $0.176B 0.00
TriSalus Life Sciences (TLSI) United States $0.158B 0.00
TerrAscend (TSNDF) Canada $0.132B 0.00
Safety Shot (SHOT) United States $0.122B 0.00
Jushi Holdings (JUSHF) United States $0.118B 0.00
FitLife Brands (FTLF) United States $0.117B 0.00
Quipt Home Medical (QIPT) United States $0.100B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Fonar (FONR) United States $0.097B 12.51
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.072B 0.00
Agape ATP (ATPC) $0.067B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.054B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Zynex (ZYXI) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.71
Nephros (NEPH) United States $0.036B 48.86
Rockwell Medical (RMTI) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
IM Cannabis (IMCC) Canada $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00